Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008881', 'term': 'Migraine Disorders'}, {'id': 'D006261', 'term': 'Headache'}], 'ancestors': [{'id': 'D051270', 'term': 'Headache Disorders, Primary'}, {'id': 'D020773', 'term': 'Headache Disorders'}, {'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D010146', 'term': 'Pain'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 250}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2006-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2008-04', 'lastUpdateSubmitDate': '2008-04-14', 'studyFirstSubmitDate': '2007-04-12', 'studyFirstSubmitQcDate': '2007-04-12', 'lastUpdatePostDateStruct': {'date': '2008-04-15', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2007-04-13', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ['Migraine', 'headache', 'observational'], 'conditions': ['Migraine Headache']}, 'descriptionModule': {'briefSummary': 'Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Subject is outpatient.\n* Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.\n* Subject is able to comprehend the study procedures and to comply with study requirements.\n\nExclusion Criteria:\n\n* Subject has other chronic pain condition(s) not associated with migraine\n* Subject is unable to understand the schedule/questionnaire.'}, 'identificationModule': {'nctId': 'NCT00460005', 'briefTitle': 'Clinical Study Of Migraine Evolution', 'organization': {'class': 'INDUSTRY', 'fullName': 'GlaxoSmithKline'}, 'officialTitle': 'A Multicenter Study to Determine the Clinical Characteristics of the Temporal Aspects of Migraine in a Canadian Population: Clinical Study Of Migraine Evolution (C-SOME)', 'orgStudyIdInfo': {'id': 'S2W106188'}}, 'contactsLocationsModule': {'locations': [{'zip': 'T2N 2T9', 'city': 'Calgary', 'state': 'Alberta', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 51.05011, 'lon': -114.08529}}, {'zip': 'V6X 1A3', 'city': 'Richmond', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 49.17003, 'lon': -123.13683}}, {'zip': 'V5Z 1M9', 'city': 'Vancouver', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'zip': 'E2L 4L2', 'city': 'Saint John', 'state': 'New Brunswick', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 45.27076, 'lon': -66.05616}}, {'zip': 'B3H 3A7', 'city': 'Halifax', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 44.64269, 'lon': -63.57688}}, {'zip': 'L8N 1Y2', 'city': 'Hamilton', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 43.25011, 'lon': -79.84963}}, {'zip': 'M5S 1B6', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'L3R 0W7', 'city': 'Unionville', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 43.869, 'lon': -79.3091}}, {'zip': 'J4L 4N5', 'city': 'Longueuil', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 45.5152, 'lon': -73.46818}}, {'zip': 'H3A 2B4', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Clinical Trials Call Centre', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}], 'overallOfficials': [{'name': 'GSK Clinical Trials, M.D.', 'role': 'STUDY_DIRECTOR', 'affiliation': 'GlaxoSmithKline'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'GlaxoSmithKline', 'class': 'INDUSTRY'}}}}